139 related articles for article (PubMed ID: 2392503)
21. Effects of chronic treatment with a cyclic AMP-selective phosphodiesterase inhibitor, rolipram, on excitatory amino acid neurotransmission systems in young and aged rat brains.
Kato H; Araki T; Chen T; Liu XH; Hiranuma T; Murase K; Itoyama Y; Kogure K
J Neural Transm (Vienna); 1997; 104(2-3):269-80. PubMed ID: 9203088
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
Shahid M; Nicholson CD
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of alprazolam-induced behavioural effects: differences with chlordiazepoxide after interaction with desipramine and rolipram, a cAMP phosphodiesterase inhibitor.
Cannizzaro G; Gagliano M; La Rocca S; Novara V; Flugy A
Pharmacol Res; 1989; 21 Suppl 1():53-4. PubMed ID: 2633187
[No Abstract] [Full Text] [Related]
24. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
[TBL] [Abstract][Full Text] [Related]
25. Age-related changes in [3H]nimodipine and [3H]rolipram binding in the rat brain.
Araki T; Kato H; Shuto K; Itoyama Y
J Pharm Pharmacol; 1997 Mar; 49(3):310-4. PubMed ID: 9231352
[TBL] [Abstract][Full Text] [Related]
26. Effect of long-term rolipram administration on the sensitivity of alpha 2-adrenoceptors in rat brain.
Mustafa MR; Stolz JF; Luscombe DK
Eur J Pharmacol; 1988 Mar; 148(2):171-7. PubMed ID: 2454198
[TBL] [Abstract][Full Text] [Related]
27. Behavioral effects of rolipram and structurally related compounds in mice: behavioral sedation of cAMP phosphodiesterase inhibitors.
Griebel G; Misslin R; Vogel E; Bourguignon JJ
Pharmacol Biochem Behav; 1991 Jun; 39(2):321-3. PubMed ID: 1658815
[TBL] [Abstract][Full Text] [Related]
28. Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram.
Wachtel H; Löschmann PA
Psychopharmacology (Berl); 1986; 90(4):430-5. PubMed ID: 3027733
[TBL] [Abstract][Full Text] [Related]
29. Effect of rolipram, a phosphodiesterase inhibitor and potential antidepressant, on the firing rate of central monoaminergic neurons in the rat.
Scuvée-Moreau J; Giesbers I; Dresse A
Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):43-9. PubMed ID: 3662698
[TBL] [Abstract][Full Text] [Related]
30. Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
Jacobitz S; McLaughlin MM; Livi GP; Burman M; Torphy TJ
Mol Pharmacol; 1996 Oct; 50(4):891-9. PubMed ID: 8863835
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
Sekut L; Yarnall D; Stimpson SA; Noel LS; Bateman-Fite R; Clark RL; Brackeen MF; Menius JA; Connolly KM
Clin Exp Immunol; 1995 Apr; 100(1):126-32. PubMed ID: 7697910
[TBL] [Abstract][Full Text] [Related]
32. CDP840: a novel inhibitor of PDE-4.
Perry MJ; O'Connell J; Walker C; Crabbe T; Baldock D; Russell A; Lumb S; Huang Z; Howat D; Allen R; Merriman M; Walls J; Daniel T; Hughes B; Laliberte F; Higgs GA; Owens RJ
Cell Biochem Biophys; 1998; 29(1-2):113-32. PubMed ID: 9631241
[TBL] [Abstract][Full Text] [Related]
33. Dual inhibition of human type 4 phosphodiesterase isostates by (R, R)-(+/-)-methyl 3-acetyl-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-3- methyl-1-pyrrolidinecarboxylate.
Tian G; Rocque WJ; Wiseman JS; Thompson IZ; Holmes WD; Domanico PL; Stafford JA; Feldman PL; Luther MA
Biochemistry; 1998 May; 37(19):6894-904. PubMed ID: 9578576
[TBL] [Abstract][Full Text] [Related]
34. Rolipram, a stereospecific inhibitor of calmodulin-independent phosphodiesterase, causes beta-adrenoceptor subsensitivity in rat cerebral cortex.
Schultz JE; Schmidt BH
Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):23-30. PubMed ID: 3016560
[TBL] [Abstract][Full Text] [Related]
35. Stereospecific binding of the antidepressant rolipram to brain protein structures.
Schneider HH; Schmiechen R; Brezinski M; Seidler J
Eur J Pharmacol; 1986 Aug; 127(1-2):105-15. PubMed ID: 3019721
[TBL] [Abstract][Full Text] [Related]
36. Single and repeated treatment with chlordiazepoxide and sodium valproate and head-twitch responses induced in rats with rolipram, a potential antidepressant drug.
Cannizzaro G; Flugy A; Gagliano M; La Rocca S; Novara V
Pharmacol Res; 1989; 21 Suppl 1():51-2. PubMed ID: 2517340
[No Abstract] [Full Text] [Related]
37. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells.
Pan X; Arauz E; Krzanowski JJ; Fitzpatrick DF; Polson JB
Biochem Pharmacol; 1994 Aug; 48(4):827-35. PubMed ID: 7521642
[TBL] [Abstract][Full Text] [Related]
38. The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior.
Iyo M; Maeda Y; Inada T; Kitao Y; Sasaki H; Fukui S
Neuropsychopharmacology; 1995 Aug; 13(1):33-9. PubMed ID: 8526969
[TBL] [Abstract][Full Text] [Related]
39. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
Itoh T; Tokumura M; Abe K
Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
[TBL] [Abstract][Full Text] [Related]
40. Effects of forskolin on spontaneous behavior, rectal temperature and brain cAMP levels of rats: interaction with rolipram.
Wachtel H; Löschmann PA; Schneider HH; Rettig KJ
Neurosci Lett; 1987 May; 76(2):191-6. PubMed ID: 3035438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
